Skip to main content
. 2020 Mar;9(3):1640–1651. doi: 10.21037/tcr.2020.01.64

Table 2. Frequency of clinically significant thrombocytopenia based on the chemotherapy regimen.

Type of cytotoxic drug No. of patients Frequency of overall thrombocytopenia, n (%) Frequency of isolated thrombocytopenia, n (%)
ACVBP 18 8 (44.4) 4 (22.2)
CHOP 246 62 (25.2) 22 (8.9)
DHAP 13 12 (92.3) 0 (0.0)
EPOCH 123 48 (39.0) 12 (9.8)
GDP 36 25 (69.4) 7 (19.4)
Gemox 29 20 (69.0) 6 (20.7)
ICE 58 52 (89.7) 12 (20.7)